Exelixis (EXEL) Interest & Investment Income (2017 - 2026)

Exelixis' (EXEL) quarterly Interest & Investment Income came in at $16.1 million in Q2 2026, down 15.46% year-on-year from $19.1 million in Q2 2025, and down 7.45% quarter-over-quarter from $17.4 million in Q1 2026.

Exelixis (EXEL) Interest & Investment Income (2017 - 2026) Analysis & Trends

Exelixis' Interest & Investment Income history runs 10 years deep, the most recent figure standing at $16.1 million for Q2 2026.

  • On a quarterly basis, Interest & Investment Income fell 15.46% year-over-year to $16.1 million in Q2 2026; TTM through Apr 2026 was $66.3 million, a 13.2% decrease from a year earlier, with the FY2026 full-year figure at $69.2 million, down 10.29% from the prior year.
  • Interest & Investment Income eased to $16.1 million in Q2 2026 per EXEL's latest filing, from $17.4 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $23.1 million in Q3 2023 and bottomed at $1.8 million in Q2 2022.
  • The 5-year median for Interest & Investment Income is $17.4 million (2026), against an average of $16.6 million.
  • Biggest YoY gain for Interest & Investment Income was 1078.9% in 2022; the steepest drop was 32.07% in 2022.
  • Year by year, Interest & Investment Income stood at $17.0 million in 2022, then increased by 25.9% to $21.4 million in 2023, then decreased by 12.53% to $18.7 million in 2024, then fell by 14.9% to $15.9 million in 2025, then gained by 1.29% to $16.1 million in 2026.
  • Per Business Quant, the three latest EXEL Interest & Investment Income figures stand at $16.1 million (Q2 2026), $17.4 million (Q1 2026), and $15.9 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 48.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 19.51 Mn
10 Exelixis 14.44 Bn 13.66 Bn 590.86 Mn 16.13 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 16.13 Mn
Jan 2, 2026 17.43 Mn
Oct 3, 2025 15.92 Mn
Jul 4, 2025 16.79 Mn
Apr 4, 2025 19.08 Mn
Jan 3, 2025 21.30 Mn
Sep 27, 2024 18.71 Mn
Jun 28, 2024 17.26 Mn
Mar 29, 2024 19.89 Mn
Dec 29, 2023 21.39 Mn
Sep 29, 2023 23.11 Mn
Jun 30, 2023 22.54 Mn
Mar 31, 2023 19.50 Mn
Dec 30, 2022 16.99 Mn
Sep 30, 2022 9.50 Mn
Jul 1, 2022 4.76 Mn
Apr 1, 2022 1.82 Mn
Dec 31, 2021 1.44 Mn
Oct 1, 2021 1.66 Mn
Jul 2, 2021 1.89 Mn